<DOC>
	<DOCNO>NCT00002104</DOCNO>
	<brief_summary>To demonstrate , patient tubercular nontubercular mycobacterium infection without HIV infection , safety thalidomide use judge symptom , physical exam , study microbiologic , immunologic , hematologic , renal , hepatic status . To demonstrate efficacy drug judge status fever , nutrition , tuberculosis lesion , immune response .</brief_summary>
	<brief_title>Placebo-Controlled Trial Safety Efficacy Thalidomide Patients With Infections Due Mycobacterium and/or HIV</brief_title>
	<detailed_description>Patients randomize receive thalidomide placebo orally 9 PM night begin anti-tuberculosis chemotherapy continue nightly 7 night . Patients follow 28 day . Patients stratify accord HIV status stage HIV infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Inclusion Criteria Patients must : Positive AFB smear and/or culture Mycobacterium tuberculosis , M. avium , mycobacterial infection , without document HIV infection . NOTE : HIVpositive patient must CD4 count &lt; 500 cells/mm3 antiretroviral therapy . One follow manifestation : Temperature 38 C least two occasion week prior study entry . Recent weight loss 5 kilogram . Pulmonary involvement one lobe involvement tissue due tuberculosis mycobacterial infection , symptomatic infection relate HIV status . Night sweat two occasion week prior study entry . NOTE : Patients must hospitalize men age 1865 postmenopausal woman age 65 . Anticipated requirement hospitalization must least 10 day . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Neuropathy disorder risk neuropathy . Required HIVpositive patient CD4 count &lt; 500 cells/mm3 : Antiretroviral therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 1998</verification_date>
	<keyword>Mycobacterium tuberculosis</keyword>
	<keyword>Mycobacterium Infections</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Mycobacterium Infections , Atypical</keyword>
	<keyword>Thalidomide</keyword>
</DOC>